DE60037664D1 - Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel - Google Patents
Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittelInfo
- Publication number
- DE60037664D1 DE60037664D1 DE60037664T DE60037664T DE60037664D1 DE 60037664 D1 DE60037664 D1 DE 60037664D1 DE 60037664 T DE60037664 T DE 60037664T DE 60037664 T DE60037664 T DE 60037664T DE 60037664 D1 DE60037664 D1 DE 60037664D1
- Authority
- DE
- Germany
- Prior art keywords
- oxa
- compounds
- choice
- long chain
- low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14810199P | 1999-08-10 | 1999-08-10 | |
US148101P | 1999-08-10 | ||
US19862100P | 2000-04-20 | 2000-04-20 | |
US198621P | 2000-04-20 | ||
PCT/US2000/021732 WO2001010429A2 (en) | 1999-08-10 | 2000-08-10 | Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60037664D1 true DE60037664D1 (de) | 2008-02-14 |
DE60037664T2 DE60037664T2 (de) | 2008-12-24 |
Family
ID=26845521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60037664T Expired - Lifetime DE60037664T2 (de) | 1999-08-10 | 2000-08-10 | Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel |
Country Status (9)
Country | Link |
---|---|
US (3) | US7816560B1 (de) |
EP (1) | EP1210082B1 (de) |
JP (1) | JP2003506406A (de) |
AT (1) | ATE382351T1 (de) |
AU (1) | AU1840101A (de) |
DE (1) | DE60037664T2 (de) |
ES (1) | ES2302697T3 (de) |
HK (1) | HK1046869A1 (de) |
WO (1) | WO2001010429A2 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999029321A1 (en) | 1997-12-11 | 1999-06-17 | The Chancellor, Masters And Scholars Of The University Of Oxford | Inhibition of membrane-associated viral replication |
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
GB0100889D0 (en) * | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
JP4585851B2 (ja) | 2002-07-17 | 2010-11-24 | アクテリオン ファーマシューティカルズ リミテッド | グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体 |
EP1534676B1 (de) | 2002-07-17 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | Piperidintriolderivate als inhibitoren von glycosylceramidsynthase |
AU2003302370A1 (en) * | 2002-09-23 | 2004-06-18 | The Chancellor, Masters And Scholars Of The University Of Oxford | Use of iminosugar derivatives to inhibit ion channel activity |
GB0313677D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compound |
GB0313678D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compounds |
CA2455018A1 (en) * | 2004-01-09 | 2005-07-09 | Delmar Chemicals Inc. | Process for the preparation of piperidine derivatives |
JP5107350B2 (ja) | 2005-06-08 | 2012-12-26 | アミカス セラピューティックス インコーポレイテッド | イミノおよびアミノ糖の精製 |
EP2399587A1 (de) | 2006-08-02 | 2011-12-28 | The University of Oxford | Liposomenbehandlung von Virusinfektionen |
US8097728B2 (en) | 2007-04-30 | 2012-01-17 | Philadelphia Health & Education Corporation | Iminosugar compounds with antiflavirus activity |
CN102427804A (zh) | 2009-03-27 | 2012-04-25 | 牛津大学之校长及学者 | 降低胆固醇水平的脂质体 |
BR112012004676A2 (pt) * | 2009-09-04 | 2019-09-24 | United Therapeutics Corp | método de tratar infecções orotomixovirais. |
GB201000499D0 (en) | 2010-01-13 | 2010-03-03 | Fleet George W J | Treatment of cystic fibrosis |
KR101784539B1 (ko) * | 2010-01-28 | 2017-10-11 | 랩터 파마슈티컬스 인코포레이티드 | 수용체 결합 단백질(rap) 펩타이드-푸코시다제 억제제 접합체를 이용한 간 질환의 치료방법 |
WO2011095772A2 (en) | 2010-02-04 | 2011-08-11 | Summit Corporation Plc | Novel iminosugar therapeutics |
GB201006434D0 (en) | 2010-04-19 | 2010-06-02 | Summit Corp Plc | Novel iminosugar combinations |
TWI519515B (zh) | 2011-12-21 | 2016-02-01 | 諾維拉治療公司 | B型肝炎抗病毒劑 |
CN104703597A (zh) * | 2012-06-06 | 2015-06-10 | 尤尼特尔滤过性微生物学有限责任公司 | 新型亚氨基糖及它们的应用 |
EA027280B1 (ru) | 2012-08-28 | 2017-07-31 | Янссен Сайенсиз Айрлэнд Юси | Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b |
CA2899706C (en) | 2013-02-28 | 2021-10-19 | Janssen Sciences Ireland Uc | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b |
US8993771B2 (en) | 2013-03-12 | 2015-03-31 | Novira Therapeutics, Inc. | Hepatitis B antiviral agents |
US9895349B2 (en) | 2013-04-03 | 2018-02-20 | Janssen Sciences Ireland Us | N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
JO3603B1 (ar) | 2013-05-17 | 2020-07-05 | Janssen Sciences Ireland Uc | مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي |
BR112015028538A2 (pt) | 2013-05-17 | 2017-07-25 | Janssen Sciences Ireland Uc | derivados de sulfamoiltiofenamida e o uso dos mesmos como medicamentos para o tratamento da hepatite b |
NO3024819T3 (de) | 2013-07-25 | 2018-07-21 | ||
RU2702133C2 (ru) | 2013-09-16 | 2019-10-04 | ЭМЕРГЕНТ ВИРОЛОДЖИ ЭлЭлСи | Производные дезоксинойиримицина и способы их применения |
CA2923712C (en) | 2013-10-23 | 2021-11-02 | Janssen Sciences Ireland Uc | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
US9169212B2 (en) | 2014-01-16 | 2015-10-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
US10392349B2 (en) | 2014-01-16 | 2019-08-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
US9181288B2 (en) | 2014-01-16 | 2015-11-10 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
RU2702109C1 (ru) | 2014-02-05 | 2019-10-04 | Новира Терапьютикс, Инк. | Комбинированная терапия для лечения инфекций вгв |
CN110483484A (zh) | 2014-02-06 | 2019-11-22 | 爱尔兰詹森科学公司 | 氨磺酰基吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 |
US9400280B2 (en) | 2014-03-27 | 2016-07-26 | Novira Therapeutics, Inc. | Piperidine derivatives and methods of treating hepatitis B infections |
CN107847762A (zh) | 2015-03-19 | 2018-03-27 | 诺维拉治疗公司 | 氮杂环辛烷和氮杂环壬烷衍生物以及治疗乙型肝炎感染的方法 |
US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
EP3356328A1 (de) | 2015-09-29 | 2018-08-08 | Novira Therapeutics, Inc. | Kristalline formen eines hepatitis-b-viruzids |
EP3442524A2 (de) | 2016-04-15 | 2019-02-20 | Novira Therapeutics Inc. | Kombinationen und verfahren mit einem kapsid-anordnungsinhibitor |
US10973801B2 (en) | 2018-03-14 | 2021-04-13 | Janssen Sciences Ireland Unlimited Company | Capsid assembly modulator dosing regimen |
US10883084B2 (en) | 2018-10-05 | 2021-01-05 | Xenotherapeutics, Inc. | Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same |
JP7431837B2 (ja) | 2018-10-05 | 2024-02-15 | ゼノセラピューティクス インコーポレイテッド | 異種移植製品及び異種移植方法 |
US11096931B2 (en) | 2019-02-22 | 2021-08-24 | Janssen Sciences Ireland Unlimited Company | Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases |
US11491148B2 (en) | 2019-05-06 | 2022-11-08 | Janssen Sciences Ireland Unlimited Company | Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO154918C (no) | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
JPS5943949B2 (ja) | 1978-09-29 | 1984-10-25 | 日本新薬株式会社 | モラノリンのn−置換誘導体 |
DE2834122A1 (de) | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
DE2853573A1 (de) | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
DE3038901A1 (de) | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
US4944572A (en) | 1983-01-13 | 1990-07-31 | Young Clinton J T | Variable aspect display |
EP0252962B1 (de) | 1985-12-23 | 1995-08-23 | Fred Hutchinson Cancer Research Center | Regulierung der retroviralen replikation, infektion und pathogenese |
DE3611841A1 (de) | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
US4861892A (en) | 1988-02-12 | 1989-08-29 | G. D. Searle & Co. | Method for synthesis of deoxymannojirimycin |
EP0350012A3 (de) | 1988-07-08 | 1990-09-05 | Meiji Seika Kaisha Ltd. | Antivirale Zusammensetzung |
US4910310A (en) | 1988-10-03 | 1990-03-20 | G. D. Searle & Co. | Synthesis of N-substituted 1,5-dideoxy-1,5-imino-L-fucitol derivatives |
US5310745A (en) * | 1988-11-03 | 1994-05-10 | G. D. Searle & Co. | Antiviral compounds |
ES2086323T3 (es) * | 1988-11-03 | 1996-07-01 | Searle & Co | Derivados del didesoxi-arabinitol como compuestos antiviricos. |
US4894388A (en) | 1988-12-22 | 1990-01-16 | Monsanto Company | Glycosidase inhibitors and use thereof |
US5011929A (en) | 1989-05-15 | 1991-04-30 | Monsanto Company | Synthesis of mannojirimycin derivatives |
US5017704A (en) | 1989-06-27 | 1991-05-21 | Monsanto Company | Fucosidase inhibitor |
US5100797A (en) | 1989-06-27 | 1992-03-31 | Monsanto Company | Fucosidase inhibitors |
US5043273A (en) | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
US5103008A (en) | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
US4996329A (en) | 1989-10-20 | 1991-02-26 | Monsanto Company | Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation |
US5013842A (en) | 1990-01-22 | 1991-05-07 | Monsanto Company | Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors |
US5030638A (en) * | 1990-02-26 | 1991-07-09 | G. D. Searle & Co. | Method of antiviral enhancement |
DE4009561A1 (de) | 1990-03-24 | 1991-09-26 | Bayer Ag | Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
EP0536402A4 (en) * | 1990-06-29 | 1993-05-12 | Nippon Shinyaku Company, Limited | Piperidine derivative |
US5200523A (en) | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
US5073273A (en) * | 1991-05-22 | 1991-12-17 | Trw Vehicle Safety Systems, Inc. | Treatment of azide containing waste |
US5276120A (en) | 1991-05-30 | 1994-01-04 | The Scripps Research Institute | Process for forming omega-deuxy-azasugars |
US5401645A (en) | 1992-03-16 | 1995-03-28 | Monsanto Company | Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles utilizing acetobacteraceae and corynebacterium |
US5286877A (en) | 1993-02-01 | 1994-02-15 | G. D. Searle & Co. | Synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol |
US6291657B1 (en) * | 1993-05-13 | 2001-09-18 | Monsanto Company | Deoxygalactonojirimycin derivatives |
AU1403795A (en) | 1994-01-13 | 1995-08-01 | G.D. Searle & Co. | Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections |
AU1876095A (en) | 1994-02-25 | 1995-09-11 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
AUPO258196A0 (en) | 1996-09-27 | 1996-10-17 | Australian National University, The | Method for determining ion channel activity of a substance |
US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
WO1998035685A1 (en) | 1997-02-14 | 1998-08-20 | G.D. Searle And Co. | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
AU753336B2 (en) * | 1997-11-10 | 2002-10-17 | G.D. Searle & Co. | Use of alkylated iminosugars to treat multidrug resistance |
WO1999029321A1 (en) * | 1997-12-11 | 1999-06-17 | The Chancellor, Masters And Scholars Of The University Of Oxford | Inhibition of membrane-associated viral replication |
US6465488B1 (en) | 1997-12-11 | 2002-10-15 | Chancellor, Masters & Scholars Of The University Of Oxford | Inhibition of glycolipid biosynthesis |
US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
ID27290A (id) | 1998-02-12 | 2001-03-22 | Searle & Co | Penggunaan senyawa 1,5-dideoksi-1,5-imino-d-glusitol tersubstitusi-n pada pengobatan infeksi virus hepatitis |
US6545021B1 (en) | 1999-02-12 | 2003-04-08 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
US7256005B2 (en) * | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
WO2001060366A1 (en) | 2000-02-14 | 2001-08-23 | Pharmacia Corporation | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
WO2001074776A1 (en) * | 2000-03-31 | 2001-10-11 | Michigan State University | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
GB0215617D0 (en) | 2002-07-08 | 2002-08-14 | Univ Leeds | Use of hepatitis C virus (HCV) p7 protein |
-
2000
- 2000-08-10 JP JP2001514949A patent/JP2003506406A/ja active Pending
- 2000-08-10 AT AT00952683T patent/ATE382351T1/de not_active IP Right Cessation
- 2000-08-10 AU AU18401/01A patent/AU1840101A/en not_active Abandoned
- 2000-08-10 WO PCT/US2000/021732 patent/WO2001010429A2/en active IP Right Grant
- 2000-08-10 ES ES00952683T patent/ES2302697T3/es not_active Expired - Lifetime
- 2000-08-10 DE DE60037664T patent/DE60037664T2/de not_active Expired - Lifetime
- 2000-08-10 US US10/031,145 patent/US7816560B1/en not_active Expired - Fee Related
- 2000-08-10 EP EP00952683A patent/EP1210082B1/de not_active Expired - Lifetime
-
2002
- 2002-11-27 HK HK02108554.9A patent/HK1046869A1/zh unknown
-
2010
- 2010-01-28 US US12/656,370 patent/US20100137365A1/en not_active Abandoned
-
2011
- 2011-03-07 US US13/064,116 patent/US9089515B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1210082A2 (de) | 2002-06-05 |
WO2001010429A2 (en) | 2001-02-15 |
AU1840101A (en) | 2001-03-05 |
WO2001010429A3 (en) | 2001-08-16 |
EP1210082B1 (de) | 2008-01-02 |
US7816560B1 (en) | 2010-10-19 |
ES2302697T3 (es) | 2008-08-01 |
US9089515B2 (en) | 2015-07-28 |
US20110184019A1 (en) | 2011-07-28 |
DE60037664T2 (de) | 2008-12-24 |
JP2003506406A (ja) | 2003-02-18 |
HK1046869A1 (zh) | 2003-01-30 |
US20100137365A1 (en) | 2010-06-03 |
ATE382351T1 (de) | 2008-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE382351T1 (de) | Langkettige n-alkyl verbindungen und deren oxa- derivate zur verwendung als anitvirale mittel | |
DE60003863D1 (de) | Dioxocyclopentylhydroxamsäure | |
EA199901031A1 (ru) | Производные бензимидазола | |
ATE402701T1 (de) | N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen | |
BRPI0410456A (pt) | compostos inibidores de hepatite c, composição farmacêutica, uso dos mesmos, bem como artigo de fabricação | |
SE0102438D0 (sv) | New compounds | |
NO20051969L (no) | Nukleosidderivater for behandling av hepatitt C virusinfeksjon. | |
ATE413411T1 (de) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
TR200103428T2 (tr) | IMPDH enzim inhibitörleri. | |
HUP0202867A2 (hu) | CCR5 antagonistákként alkalmazható piperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
DE69028552T2 (de) | Diaromatische substituierte verbindungen gegen den aids-virus | |
GEP20032995B (en) | 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists | |
PL1802650T3 (pl) | 3-Etero i 3-tioetero podstawione pochodne cyklosporyny do leczenia i zapobiegania zakażeniu wirusem zapalenia wątroby typu C | |
ATE249219T1 (de) | Antivirale verbindungen | |
TR200100671T1 (tr) | Antiviral indoloksoasetil piperazin türevleri | |
DE60124761D1 (de) | Chinoline und deren in der 4-stellung durch eine piperazinhaltige gruppe substituierte nitrogenierte derivate und deren verwendung als antibakterielle mittel | |
EA200300819A1 (ru) | Производные нуклеозидов в качестве ингибиторов рнк-зависимой рнк вирусной полимеразы | |
TR200002617T2 (tr) | Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi | |
ATE466932T1 (de) | Vermehrung von viren in zellkultur | |
DE60211539D1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
EA200000836A1 (ru) | Применение n-замещенных 1,5-дидезокси-1,5-имино-d-глюцитных производных для лечения инфекций, вызываемых вирусами гепатита | |
BR0309118A (pt) | Derivados de tropano úteis em terapêutica | |
AR014554A1 (es) | Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infecciones | |
PT763036E (pt) | Derivados ciclicos de pirrole e seu uso farmaceutico | |
BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |